Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers
Titel:
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers
Auteur:
Muñoz, Delicias Escartín, Antonio Dapena, Dolores Coret, Francisco Fernández-Uría, Dionisio Pérez, Domingo Casanova, Bonaventura Guijarro-Castro, Cristina Munteis, Elvira del-Campo Amigo, María Pego, Robustiano Calles, Carmen García-Rey, César Monsalve, Nuria Sánchez-Matienzo, David